ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • P2X7R Inhibition Impairs In Vitro Training of Macrophages

    H. H. Lancia1, R. Sanchez2, A. G. Lellouch1, C. L. Cetrulo1, J. Ochando3, G. Benichou4

  • P2X7R Signaling Controls Exosome Release by Macrophages and Donor MHC Cross-Dressing After Skin Transplantation

    H. H. Lancia1, N. Carnel2, A. G. Lellouch1, C. Cetrulo1, G. Benichou2

  • p40 Homodimers Stimulate Graft Dendritic Cells to Produce IL-15 Driving Endogenous Donor-Reactive Memory CD8 T Cell Activation within High-Risk Cardiac Allografts

    H. Tsuda1, A. Valujskikh2, R. Fairchild3

  • PACAP-Mediated Autophagy Prevents Liver Ischemia Reperfusion Injury in OLT

    Z. Xue, B. Yang, R. Busuttil, J. Kupiec-Weglinski, H. Ji

  • Palliative Care for the Patients with Failing Kidney Allograft: Kraft Survey

    N. Murakami1, S. Gelfand1, A. J. Reich1, R. Leiter2, J. Lakin2, J. T. Adler3, E. Lu4, S. Ong5, B. P. Concepcion6, N. Singh7, H. Murad8, P. Anand9, S. Ramer10, D. Dadhania11, K. Lentine12, T. Alhamad13

  • Pancreas Transplants Outcomes in Diabetes Mellitus Type 1 and Type 2 in the 21st Century: Are They Two Different Populations?

    M. Merzkani1, H. Murad2, M. Wang1, V. Hu1, M. Ji3, Y. Al-Hosni1, O. Alzahabi1, M. Zayed1, J. Wellen4, K. Lentine5, S. Chang6, T. Alhamad7

  • Pancreatic Islets Engineered with Thrombomodulin Show Enhanced Engraftment in an Intraportal Transplantation Model by Mitigating Instant Blood-Mediated Inflammatory Reactions

    A. Turan1, L. Zhang2, M. Tarique2, V. Ulker2, E. Yolcu3, H. Shirwan3

  • Parainfluenza Type 3 Infection in Solid Organ Transplant Recipients

    G. Motoa1, M. A. Mendoza1, M. Raja1, J. Simkins2, S. Anjan2, E. Martin2, A. Phancao2, N. Sinha2, L. Abbo1, G. Guerra2, Y. Natori2

  • Parathyroid Allo-Transplantation: A Case Series

    P. Di Cocco1, M. Spaggiari2, H. Kittle1, A. M. Fratti2, S. Akshelyan2, J. Almario Alvarez1, E. Benedetti2, I. Tzvetanov2

  • Parathyroidectomy versus Cinacalcet in the Treatment of Tertiary Hyperparathyroidism After Kidney Transplantation

    C. Baek

  • Passenger Lymphocyte Syndrome Presented as Hemolytic Anemia After Small Bowel Transplantation: A Case Report

    M. Kim1, D. Kim1, J. Lim1, J. Jung2, J. Kim3, J. Hwang1

  • Pathological Changes in Kidney Allografts Associated with COVID-19 Vaccination

    S. Shelton, N. Hellenga, P. Burke

  • Patient and Graft Survival for Simultaneous Kidney and Liver Transplant Recipients from Hepatitis C Viremic Donors: A Unos Database Analysis

    Z. Haddadin, A. Parsikia, H. Kaul, N. Chandolias, R. Zaki, K. Khanmoradi

  • Patient and Provider Perspectives on Telehealth Clinic Visits Precipitated by the Covid-19 Viral Pandemic

    L. Adamski1, C. Alvarez1, M. Patterson2, C. Shen3, G. Kaur3, F. K. Butt3

  • Patient Definitions of Transplant Success of Upper Extremity VCA

    M. Downey1, B. Kuramitsu2, J. Gacki-Smith2, K. Vanterpool1, M. Luken3, M. Nordstrom3, T. Riggleman3, C. Cooney1, M. Levan1, S. Tintle3, G. Brandacher1, S. Jensen2, G. Dumanian2, E. Gordon2

  • Patient Outcomes After Heart and Double Lung Transplant from a Single High-Volume Center

    R. P. Brumer1, A. Goodarzi2, R. Chihara1

  • Patient Preferences for Waiting Time and Kidney Quality: A Discrete Choice Experiment

    S. Mehrotra

  • Patient Reported Outcomes Following Renal Transplantation: The Future of Holistic Post-Transplant Care

    H. V. Spiers1, S. Frame2, R. Heape3, K. Clark2, A. Altinar2, L. Ross2, H. Wells2, A. Simpson3, J. Chilcot3, L. Hughes3, D. M. Summers1, J. Weinman3, M. Hotopf3, A. J. Cronin2

  • Patient-Reported Barriers to Living Kidney Donor Follow-Up

    B. Orandi, R. Reed, H. Qu, G. Owens, S. Brooks, C. Killian, V. Kumar, S. Sheikh, R. Cannon, C. Lewis, J. Locke

  • Patient-Reported Physical Function Correlates with Liver Frailty Index and 4-Meter Gait Speed in Patients with Cirrhosis

    A. J. Thuluvath, J. Peipert, K. Belfanti, S. Morrissey, O. Siddiqui, J. Levitsky, Z. Dietch, A. Flores, D. P. Ladner

  • PCR-Enhanced Performance Characteristics of TruGraf Gene Expression Profile in Kidney Transplant

    P. West-Thielke1, J. Fleming1, C. Miller1, N. Grund1, A. Sutton1, R. Sinha2, M. Miller2, S. Kleiboeker2, J. Weems3

  • PD-1 Expression on CD8+ T Cells Contributes to the Establishment of Mixed Chimerism-Based Operational Tolerance

    C. J. Little, S. C. Kim, J. Fechner, J. Post, M. Winslow, D. B. Kaufman

  • Pd-1 Licenses Activated Treg for Lymphatic Migration

    W. Piao1, L. Li1, V. Saxena1, K. Hippen2, M. Shirkey1, B. Blazar2, I. Lape3, y. zhang3, J. Bromberg1

  • Pediatric Acute Liver Failure: Patient Factors Associated with Higher Mortality

    J. Ascher Bartlett1, C. Weaver1, S. Barhouma2, L. Houshmand2, B. Rocque2, K. Etesami2, R. Kohli1, J. Emamaullee2

  • Pediatric Kidney Transplant Delays Due To Respiratory Viruses: A Provider Survey

    T. A. Heald-Sargent1, S. Manz2, T. Barton3, P. Verghese4

  • Pediatric Liver Transplant Factors That Influence Tacrolimus Absorption

    M. Chandran1, D. Yoeli1, A. Sater2, F. Karrer1, M. Adams1

  • Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Provisional Data Report of a Multicenter, Open-Label, Efficacy and Safety Study

    A. Abdellatif1, L. Zhao2, K. Cherny2, B. Marder2, J. D. Scandling3, K. Saag4

  • Pegloticase Use in Renal Transplant Recipients with Gout: Findings from an Insurance Claims Database Study

    C. A. Shadur1, B. Marder2, C. Vesel2, B. LaMoreaux2

  • Pegylated Lacritin N-104 Promotes Mouse Islet Stabilization and Prevents Diabetes Progression in the Non-Obese Diabetic (NOD) Mouse Model

    M. Ma1, P. Chhabra1, G. Laurie2, K. L. Brayman1

  • Perception Regarding Live Kidney Donation in the General Population of South Korea

    H. Lee1, E. Kang2, J. Lee3, Y. Jang1, S. Park4, Y. Kim5, H. Kim6, Y. Kim1, D. Kim1, K. Joo1, Y. Kim1, I. Choi6

  • Performance of 2021 Creatinine and Cystatin C Based Equations without Race in Living Kidney Transplant Donors

    A. Liaqat, H. Sawaf, L. Cholin, S. Arrigain, A. Wee, J. Schold, J. Augustine, E. Poggio

  • Performance of Aged Liver Grafts in a Rat Model of Normothermic Ex Vivo Liver Machine Perfusion

    S. Moosburner1, M. Zimmer1, J. M. Gassner1, N. Roschke1, N. Berndt2, J. Michelotto1, K. H. Hillebrandt1, J. Pratschke1, I. M. Sauer1, N. Raschzok1

  • Performance of Donor Derived Cell Free DNA (dd-cfDNA) in Diagnosing Subclinical and Clinical Acute Rejection in Kidney Transplant Recipients

    T. Cober, P. West-Thielke, C. Miller, N. Grund, M. Altrich, A. Sutton, R. Sinha, M. Miller, S. Kleiboeker, J. Weems

  • Performance of Kidney Transplantation in a Resource-Poor Setting of Southeast Nigeria- A Review of the First Ten Cases

    C. G. Okwuonu1, O. J. Chimezie2, G. O. Achor3, N. M. Erondu4, C. Ralph-Iheke5, S. Alhassan6

  • Performance of Race-Independent GFR Estimating Formulas, CKD-EPI2021 and NMR-GFR Post Kidney Transplantation

    E. Schiffer1, F. Stammler2, M. Grassi2, E. Schiffer2

  • Performance of Updated Estimated Glomerular Filtration Rate Equations in Black Living Kidney Donor Candidates

    J. Augustine, A. Liaqat, S. Arrigain, J. Schold, E. Poggio

  • Perfusate Cell-Free DNA Content is a Potential Marker of Cellular Injury During Hypothermic Machine Perfusion of Porcine Kidneys Subject to Prolonged Warm Ischemia

    V. Boominathan1, M. Willman1, N. Battula2, A. Zarrinpar1, S. Duarte1

  • Perfusate Il-6 Levels During Liver Nmp Are Predictive For Hemodynamic Response And Catecholamine Demand After Reperfusion In The Recipient

    A. Weissenbacher1, S. Mathis2, B. Cardini1, C. Bogensperger1, G. Putzer2, L. Gasteiger2, T. Resch1, R. Oberhuber1, D. Öfner1, T. Hell3, J. Martini2, S. Schneeberger1

  • Perfusate Metabolites and Association with Pump Perfusion and Allograft Failure

    R. X. Liu1, N. Koyawala2, H. T. Philbrook2, I. Hall3, P. Reese4, S. Mohan5, M. Doshi6, C. Parikh1

  • Pericardial Effusion: A Potential Late Complication of COVID-19 Infection

    O. Sogbein, A. Rizvi, M. Mujtaba, S. Hussain

  • Perioperative Cardiovascular Outcomes of Pre-Transplant ECMO in Recipients of Lung Transplant

    F. Anjum1, R. Munshi2, A. M. Courtwright1, M. M. Crespo1, J. C. Salgado1, J. D. Christie1, V. N. Ahya1, N. Patel1, D. Hadjiliadis1, E. Clausen1, M. Cevasco3, E. E. Cantu3, C. A. Bermudez3, J. M. Diamond1

  • Perioperative IL-6 Blockade Promotes Intra-Graft Regulation and Prevents Costimulation-Blockade Resistant Rejection

    M. Muckenhuber1, K. Mengrelis1, A. M. Weijler1, V. Kainz1, R. Steiner1, H. Regele2, T. Wekerle1

  • Perioperative Management of Live Donor Liver Transplantation: National Survey Results

    C. Crouch1, J. Ko2, A. Hendrickse3, S. Kumar4, M. Little5, T. Sakai6

  • Peripheral Blood Immune Cell Profiles of Corneal Transplant with and without Acute Rejection

    J. Hjortdal1, M. Griffin2, C. C. Murphy3, S. Brouard4, N. Degauque4

  • Personalized Medicine Using Next-Generation Sequence for Kidney Transplant Recipients

    J. Sanchez-Garcia, D. Morris, E. Darling, M. Dantis-Tan, J. Olson, K. Gaid, A. Raza, S. Anand

  • Perturbations in Podocyte Transcriptome and Biological Pathways Induced by Injury Caused by FSGS Associated Circulating Factors

    P. Rashmi1, T. Sigdel1, D. Rychkov1, I. Damm1, F. Vincenti1, C. Craik1, J. Reiser2, M. Sarwal1

  • Perturbing Proteostasis to Deplete Plasma Cells

    A. Rossi1, A. Burg1, K. Roskin1, A. Shields2, R. Alloway2, E. Woodle2, D. Hildeman1

  • PFIC- Outcome and Time to Transplant After Biliary Diversion According to Genetic Subtypes

    M. Schulze1, A. Sahloul2, E. Lainka3

  • Pharmacogenomic Dosing in Kidney Transplant Patients Converted from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®)

    K. D. Belfield1, K. J. Armstrong2, D. Malhotra3, G. F. Girone1

  • Phase I/ii Car-Treg Cell Therapy Clinical Trial To Induce Long-term Tolerance In Liver Transplant Patients

    A. Sanchez-Fueyo1, A. Taylor1, D. Collin2, C. Nathalie2, S. Chris2, M. Martinez-Llordella2, N. Belmonte2, I. McGill2, D. Hartl2

  • Phenotypes of Non-Citizen Kidney Transplant Recipients in the United States by Machine Learning Consensus Clustering

    P. Vaitla1, C. Thongprayoon2, C. Jadlowiec3, N. Leeaphorn4, S. Mao2, M. Mao2, A. Prakrati5, M. Cooper6, W. Cheungpasitporn2

  • Phenytoin To Expedite Sirolimus & Tacrolimus Elimination: A Case Report

    A. Lemke, B. A. Boilson, R. Razonable, S. A. Bernard

  • Physician Preferences When Selecting Candidates for Marginal Quality Kidney Offers: A Discrete Choice Experiment

    S. Mehrotra

  • Physicians Are Perfectionists and Patients Are Pragmatic? Comparing Physician and Patient Definitions of Success in Liver Transplantation

    I. Woelfel1, D. Faulkner1, W. Kellett1, K. Washburn2, A. Schenk1

  • Physiological Age by Artificial Intelligence-Enhanced Electrograms as a Novel Biomarker of Mortality in Kidney Transplant Candidates

    E. Lorenz, I. Zaniletti, B. Johnson, T. Petterson, W. Kremers, C. Schinstock, H. Amer, A. Cheville, N. LeBrasseur, A. Baez-Suarez, Z. Attia, F. Lopez-Jimenez, P. Friedman, C. Kennedy, A. Rule

  • Place Based Risk for Early Rejection in Lung Transplant

    W. M. Tsuang1, X. Wang2, J. Curtis3

  • Placement of COVID Positive Organs: An Early Analysis

    A. M. Hawxby, R. Ketcham, J. P. Orlowski, R. Squires, C. Hostetler

  • Plasma Donor-Derived Cell-Free DNA Longitudinal Kinetics After Kidney Transplantation in Children

    R. Dandamudi1, S. Federman2, R. Woodward2, S. Dholakia2, L. Walther1, V. Dharnidharka1

  • Plasma from Patients with Primary Focal Segmental Glomerulosclerosis Induce Development of Sclerotic Glomeruli in Kidney Organoids

    A. Kumar Gupta1, E. Minocha1, J. A. Wertheim1, L. Gallon2

  • Plasma Galectin-3 is Predictive of Post-Transplant Infection in Pediatric Liver Transplant Recipients

    D. Yoeli, A. Chaidez, Y. Luo, J. Huang, N. Limon De La Rosa, N. Nakra, Z. Wang, E. Cervantes-Alvarez, M. Adams, C. Mack, C. Huang, N. Navarro-Alvarez

  • Plasmapheresis and Rituximab for Prevention of Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation

    A. N. Yun1, A. W. Rogers1, J. C. Krisl1, A. Kagan2, H. E. Adrogue2, A. J. Khan2, P. Khairallah2, S. G. Yi3, M. J. Hobeika3, R. R. McMillan3, H. Podder3, A. O. Gaber3, R. J. Knight3

  • Plasmapheresis Dependent AT1R Antibody Associated Recurrent FSGS After Living Donor Kidney Transplantation

    R. K. Mallavarapu

  • Polarized Il-6 Secretion from Lymphatic Endothelial Cells Promotes Treg Conversion to Extregs

    V. Saxena1, W. Piao1, L. Li1, M. W. Shirkey1, R. Lakhan1, S. Walden2, K. L. Hippen2, B. Blazar2, J. S. Bromberg1

  • Polymorphisms in Ctla-4 Predict De Novo Donor Specific Antibody Formation After Kidney Transplantation

    K. Ono, K. Ide, H. Yamane, S. Akimoto, N. Tanimine, H. Tahara, M. Ohira, Y. Tanaka, H. Ohdan

  • Pooled Prevalence of Pulmonary Embolism in Lung Transplant Recipients – A Meta-Analysis

    F. Pyarali, A. Stevens, R. Rampolla

  • Poor Outcomes in Patients with Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions

    K. Wu1, D. Schmidt1, C. Lopez del Moral1, Q. Zhang1, F. Halleck1, M. G. Naik1, N. Lachmann2, B. Rudolph3, K. Budde1

  • Poor Prognosis of Proliferative Glomerulonephritis with Monoclonal IgG Deposits in Renal Allografts: A Retrospective Multicenter Study from China

    Q. Wu1, D. Liang1, X. Ni1, T. Song2, X. Wu3, M. Zhang1, J. Chen1, D. Cheng1, W. Jiqiu1

  • Poor Tolerability of CFTR Modulator Therapy in Lung Transplant Recipients

    C. Doligalski, C. McKinzie, A. Yang, R. Coakley

  • Portal Hypertension Inhibits the Antitumor Effect of Liver-Resident NK Cells Through IL-33 Signal

    Y. Imaoka, M. Ohira, K. Sato, K. Imaoka, R. Nakano, Y. Tanaka, H. Ohdan

  • Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy

    K. Etesami1, R. Hogen2, J. Cervantes3, Y. Kwon4, S. Zielsdorf3, J. Emamaullee3, Y. Genyk3

  • Portal Vein Thrombosis and DCD Liver Transplantation: Dangerous Combination or Clinical Opportunity?

    E. Calderon1, Y. Chang2, P. Lu1, A. M. Durant3, D. Derakshani4, M. L. Anderson4, E. R. Luque Villa2, C. Jadlowiec2, K. Reddy2, A. Moss2, A. K. Mathur2

  • Portal-Endocrine and Gastric-Exocrine Drainage Technique in Pancreatic Transplantation

    H. Shokouh-Amiri1, M. S. Naseer2, R. McMillan1, D. Aultman1, S. Tandukar1, N. Singh1, G. B. Zibari1

  • Posoleucel as Preemptive Therapy for BKV Infection in Kidney Transplant Recipients: Safety and Tolerability in a Phase 2 Trial

    R. K. Wali1, M. Singh2, D. Wojciechowski3, M. J. Ansari4, B. Lonze5, V. Nair6, A. Sharma7, S. Knechtle8, F. Cardarelli9, A. Chandraker10

  • Possible Recurrence Must Not Limit Kidney Transplantations for Patients with Focal Segmental Glomerulosclerosis

    A. Angeletti, M. Gentile, G. Ghiggeri, M. Bruschi, F. Lugani, G. Caridi

  • Post Heart Transplant Outcomes of Desensitized Durable Mechanical Circulatory Support Patients

    J. Youn1, D. Kim2, J. Choi2, K. Kim1, I. Kim3, E. Kransdorf4, D. Chang4, M. Kittleson4, J. Patel4, R. Cole4, J. Moriguchi4, D. Ramzy5, F. Esmailian5, J. A. Kobashigawa4

  • Post Transplant Virologic Outcomes in DCD Kidney Transplant Recipients Treated with Thymoglobulin Induction Immunosuppression and Maintenance Belatacept vs Calcineurin Inhibitor Therapy

    T. Engebretsen1, M. Kueht1, A. Lea2, M. Mujtaba3

  • Post-Acute Sequelae of Sars-Cov-2 Infection in Solid Organ Transplant Recipients

    S. Alasfar1, T. Chiang1, A. J. Snyder2, M. T. Ou1, B. Boyarsky1, A. T. Abedon1, J. L. Alejo1, W. Cochran1, J. M. Garonzik-Wang3, D. C. Brennan1, T. Vannorsdall1, D. L. Segev1, R. K. Avery1

  • Post-Allocation Policy and Changes in Gender Disparities in Access to Simultaneous Liver and Kidney Transplantation

    G. Peschard1, M. Wang2, Y. Al-Hosni3, K. Lentine4, S. Chang2, T. Alhamad5

  • Post-Kidney Donation Pregnancy Complications and Long-Term Outcomes

    E. F. Palzer1, E. S. Helgeson1, M. Evans2, D. Vock1, A. Matas3

  • Post-Kidney Transplant Body Mass Index Trajectories Are Associated with Graft Loss and Mortality

    Y. Liu1, V. Bendersky1, X. Chen1, M. Harhay2, D. Segev1, M. McAdams-DeMarco1

  • Post-Kidney Transplant Dementia Risk by Modifiable Risk Factors and CNIs Among Older Recipients

    Y. Chen1, J. Ahn1, N. Chu1, S. Bae1, M. A. Schnitzler2, G. Hess3, K. Lentine4, D. Segev5, M. McAdams-DeMarco1

  • Post-Kidney Transplant Valacyclovir or Valganciclovir for EBV Prophylaxis: A Randomized Controlled Trial

    P. S. Verghese1, A. Matas2, S. Chinnakotla2, M. Evans3, H. Balfour Jr4

  • Post-Kidney Transplant Valacyclovir versus Valganciclovir for CMV Prophylaxis: A Randomized Controlled Trial

    P. S. Verghese1, A. Matas2, S. Chinnakotla2, M. Evans3, H. Balfour Jr4

  • Post-Operative Day 1 Galectin-3 is Predictive of Early Allograft Dysfunction in Liver Transplantation

    D. Yoeli, T. Ferrell, I. Rodriguez, N. Limon De La Rosa, N. Nakra, Z. Wang, E. Cervantes-Alvarez, R. Choudhury, M. Adams, T. Nydam, E. Pomfret, C. Huang, N. Navarro Alvarez, H. Moore

  • Post-Simultaneous Kidney and Pancreas Transplant Outcomes in Type 2 Diabetes Compared to Type 1 Diabetes

    L. Liriano1, Y. Al Azzi2, S. Kapoor2, S. Jain1, M. Ajaimy3, P. Loarte2, C. Pynadath4, J. Graham2, S. Stefan1, E. Akalin5

  • Post-Transplant Lymphoproliferative Disorder in Kidney and Simultaneous Pancreas and Kidney Transplant Recipients Predictors, and Patient and Allograft Outcomes

    M. A. Mohamed1, E. A. Yousif1, V. Manchala2, F. Aziz3, N. Garg4, S. Parajuli4, D. Mandelbrot5, B. Astor1

  • Post-Transplant Outcomes and Financial Burden in Donation After Cardiac Death Donor Liver Transplant After the Implementation of Acuity Circle Allocation Policy

    S. Shimada, T. Shamaa, T. Ivanics, T. Kitajima, M. Adhnan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

  • Post-Xenotransplant Antibody Specificities Against Swine, Monkey and Human Leukocyte Antigens in Highly Sensitized Nonhuman Primate Model

    I. DeLaura, I. Anwar, M. Manook, D. Olaso, J. Yoon, R. Baldi, A. Jackson, S. Knechtle, J. Kwun

  • Practices and Perceptions of Living Donor Liver Transplant, Non-Directed Donation, and Liver Paired Exchange: A National Survey

    A. Kaplan1, R. Rosenblatt1, W. Jackson2, R. Brown1, B. Samstein1

  • Pre- Kidney Transplant Coronary Angiography Findings Based on Vascular Calcification on CT in Patients with a Negative Stress Test

    S. Valavoor, A. Sharfuddin, W. Goggins, M. Jan, O. Adebiyi, M. Yaqub

  • Pre-Emptive Rituximab to Prevent Post Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Kidney Transplant Recipients with EBV DNAemia: A Case Series from the Pediatric Nephrology Research Consortium (PNRC)

    I. Ashoor1, S. Ranabothu2, S. Al-Akash3, A. Moudgil4, Y. Shi4, S. Kizilbash5, D. Puliyanda6, V. Dharnidharka7

  • Pre-Emptive Rituximab Use for Epstein-Barr Virus (EBV) Viremia in Cardiothoracic Solid Organ Transplant Recipients

    B. Astorga, A. Loethen, L. Potter

  • Pre-Transplant Desensitization Utilizing Intravenous Immune-Globulin and Tocilizumab: A Single Center Experience

    I. Moinuddin, M. Miles, S. Sterling, A. Brown, P. Kimball, G. Gupta

  • Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology

    A. Shingina1, J. N. Menachem1, S. Brown1, I. A. Ziogas2, W. K. Wu3, M. J. Izzy4, J. Liang1, K. Washington1, S. Alexopoulos5

  • Pre-Transplant Ex-Vivo Analysis of Kidney Vasculature and Perfusion Using Contrast Computed Tomography

    A. Feizi1, J. R. DiRito1, M. Harris1, J. C. Stendahl1, S. Spindler1, C. M. Edwards1, T. Lysyy1, S. Lee1, N. Boutagy1, A. Fehér1, P. Yoo1, S. A. Hosgood2, D. C. Mulligan1, M. L. Nicholson2, A. J. Sinusas1, D. J. Haakinson1, G. T. Tietjen1

  • Pre-Transplant Frailty Predicts Infection After Liver Transplant in a Multi-Center Study of Older Adults

    M. Malinis1, M. Abidi2, E. Benamu2, N. Jakharia3, N. Law4, R. Sigler4, R. Nog5, S. Olivier5, S. Taimur6, N. Theodoropoulos7, J. Schaenman8

  • Pre-Transplant Self-Report of Length of Sobriety is Not Significantly Related to Early Return to Alcohol Use Post Transplant

    J. Esswein1, A. Powell1, H. Bruschwein2, S. Weinland1

  • Pre-Transplant Vaccine Induced SARS-CoV-2 Antibodies Decrease Following Induction Therapy for Kidney Transplantation

    N. Barros1, A. C. Ermel1, A. Sharfuddin2, W. Goggins3, J. Fridell2

  • Pre-Transplantation Liver Immunoadsorption Reduces Liver-Specific Antibody and Complement Deposition without Prolonging Survival in Porcine to Baboon Liver Xenotransplantation

    D. J. Cloonan1, T. Coe1, N. Serifis1, R. Matheson1, S. Maggipinto1, D. Firl1, R. Anand2, J. Layer2, L. Queiroz2, K. Stiede2, K. Hall2, M. Youd2, W. Qin2, M. Curtis2, S. Kimura1, I. Rosales1, J. Markmann1

  • Pre-Vaccine Antibodies Against Seasonal Betacoronaviruses Are Associated with Decreased Antibody Response to SARS-CoV-2 mRNA Vaccination in Solid Organ Transplant Recipients

    A. Karaba1, W. Zhou1, T. Aytenfisu1, T. S. Johnston1, O. Akinde1, Y. Eby1, A. Abedon1, J. Alejo1, C. Qin1, J. Garonzik-Wang2, S. Klein1, J. Bailey1, A. Cox1, J. Blankson1, D. Segev1, A. Tobian1, W. Werbel1

  • Prebiotic Supplementation In Kidney Transplant Recipients For Preventing Infections And Gastrointestinal Upset: A Randomized Controlled Feasibility Study

    S. Chan1, C. M. Hawley1, E. M. Pascoe2, C. Z. Cao2, S. B. Campbell2, K. L. Campbell3, R. S. Francis2, R. Hale1, N. M. Isbel4, M. Morrison5, D. W. Johnson2

  • Preclinical Evaluation of Functional Survival of Stem Cell Derived Islets Microencapsulated in Alginate with CXCL12 in Non-Human Primates without Immunosuppression

    M. C. Poznansky

  • Predicted Performance of Bayesian-Based Precision Dosing Software for Tacrolimus

    A. Seghezzo1, J. Kerr1, A. Gupta2, A. Ta2, L. Powell2, A. Feist3

  • Predicting Long Term Kidney-Allograft Failure: Machine Learning vs Traditional Statistical Models

    A. Truchot1, M. Raynaud1, c. lefaucheur2, O. Aubert1, A. Loupy1

  • Predicting Urinary Tract Infections Requiring Hospitalization in Living Donor Kidney Transplant Recipients

    A. Dinh, T. Copeland, D. Adey, E. Ku

  • Prediction Model of Post-Donation Renal Function Using Dynamic Kidney CT Volumetry in Living Donor

    S. Lim1, J. Kwon2, Y. Ko1, H. Kwon1, J. Jung1, H. Kwon1, Y. Kim1, J. Park2, K. Lee2, S. Shin1

  • Prediction of Delayed Graft Function After Deceased Donor Kidney Transplantation Using Machine Learning and Sequential Donor Data

    J. Sageshima1, J. Yu1, H. Lala Gul1, F. De Leon1, N. Goussous1, N. Mineyev1, P. Than1, K. Jen2, R. Perez1

  • Prediction of ESRD Risk in Living Kidney Donors Through Thirty Years Post-Donation

    A. Massie1, J. Snyder2, M. Levan1, D. Brennan1, F. Al-Ammary1, D. Segev1

  • Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help?

    A. Kwong1, W. Kim1, D. Schladt2, A. Wey2, J. Snyder2, A. Israni2, J. Lake3

  • Predictive Value of Abnormal Hemodynamic Response to Dobutamine Stress Echocardiography in Liver Transplant Recipients

    M. Groose, A. Peotter, L. Hammel

  • Predictors Associated with Survival Outcomes for DCD and DBD Renal Transplants from D4 Donors. A Registry Based Machine Learning Analysis (MLA)

    H. Sharma1, A. Sharma2

  • Predictors of Delayed Kidney Graft Function Following Combined Liver and Kidney Transplantation

    P. Vincenzi1, J. Gaynor2, R. Vianna3, G. Ciancio3

  • Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection

    D. Kumar1, R. Winstead1, H. Iftikhar1, R. Minniti1, S. Khorsandi1, J. Christensen1, I. Yakubu1, I. Moinuddin1, L. Kamal1, P. Halloran2, G. Gupta1

  • Predictors of Short and Long Term Outcomes of Donor After Cardiac Death (DCD) versus Donor After Brain Death (DBD) Kidney Transplantation from Supra Marginal Donors ( D4). A Machine Learning Analysis (MLA) of NHSBT Registry Data Since Year 2000

    H. Sharma1, A. Sharma2, T. Gunawardhane1, B. Devkaran1, K. Kapoor1, S. Mehra1

  • Preemptive  Therapy for Cytomegalovirus (CMV) Disease Prevention in High-Risk CMV Donor Seropositive Recipient Seronegative (D+/R-) Liver Transplant Recipients in a Real-World Setting 

    K. M. Doss1, C. Kling1, M. R. Heldman1, N. Singh2, M. Wagener3, C. E. Fisher1, A. Limaye1

  • Preemptive Therapy in Cytomegalovirus (CMV) Seropositive Donor to Seronegative Recipient Liver Transplants

    J. Revollo, E. Aldag, K. Cooper, B. Noell, V. Casingal, K. Gajurel

  • Preferred Language And Disease Severity Predict Evaluation For Liver Transplantation Among Patients Admitted With Alcoholic Hepatitis

    D. J. Cloonan1, J. Broekhuis2, T. Coe1, S. Criss3, S. Li3, E. Bethea1, H. Yeh1, L. Dageforde1

  • Pregnancy After Heart Transplant Does Not Negatively Impact Long Term Patient Survival

    M. J. Moritz1, D. Lee2, C. Madu2, S. Hossain3, L. A. Coscia4, S. Rao5, S. Constantinescu6

  • Preliminary Data of the Safety and Immunogenicity Protocol of Vaccination for SARS-CoV 2 in Solid Organ Transplant Patients in Argentina

    S. K. Villamil Cortez1, J. R. Geffner2, L. A. Barcan3, P. Remersano2, A. Smud3, A. Villamil4, N. C. Imperiali1, S. R. Groppa1, C. A. Mombelli1, V. A. Suarez Muñoz1, C. Belziti5, F. Marcelo6, S. Di Pietrantonio7, G. J. Rosa Diez1, M. C. Giordani1

  • Preoperative Antibiotics Administration is Important to Prevent Hand Port-Site Infection After Hand-Assisted Laparoscopic Donor Nephrectomy for Living-Donor Kidney Transplantation

    T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, N. Goto, T. Ichimori, S. Narumi, Y. Watarai

  • Preoperative Blood Pressure and Risk of Delayed Graft Function in Deceased Donor Kidney Transplantation

    S. Wazir, M. Abbas, P. Ratanasreemehta, C. Zhang, C. M. Puttarajappa

  • Prescription Opioid Use May be More Detrimental to Younger Kidney Transplant Recipients: A Machine Learning Approach

    J. Kim1, S. Bae1, J. Ahn1, K. Lentine2, D. Segev1, M. McAdams-DeMarco1

  • Presence of AT1R Antibody Pre-Transplant Does Not Correlate with Rejection in a Large Pediatric Kidney Transplant Cohort

    K. Hitchman1, P. K. Shah1, D. Fritze1, R. Hinojosa2, D. Ranch1

  • Presence of Infiltrating Regulatory T Cells in the Cardiac Xenografts and Their Potential Role in Graft Survival

    A. K. Singh1, C. E. Goerlich1, G. Braileanu1, A. Hershfeld1, T. Zhang1, I. Tatarov1, B. Lewis1, F. Sentz1, D. Ayares2, B. Griffith1, M. M. Mohiuddin1

  • Pretransplant microRNAs in Liver Perfusate Associate with Early Allograft Dysfunction

    E. Bardhi, E. Williams, J. McDaniels, T. Rousselle, V. Mas, D. Maluf

  • Pretransplant Recipient TNFR2+T Regulatory Cell Frequency Predicts Long-Term Outcomes After Kidney Transplantation

    A. Kouyoumdjian, N. Saberi, S. Negi, J. Tchervenkov, S. Paraskevas

  • Pretransplant Rifaximin Treatment Improves Liver Transplant Outcomes in Mice and Humans

    H. Kojima, S. Kageyama, T. Ito, D. Noguchi, H. Hirao, K. Kadono, K. J. Dery, F. Kaldas, J. Kupiec-Weglinski

  • Pretransplant Transcriptome Predicts 24-Month Kidney Function

    E. Bardhi1, K. Archer2, D. Maluf1, J. McDaniels1, T. Rousselle1, E. Akalin3, T. Mueller4, V. Mas1

  • Prevalence and Characteristics of Covid-19-Associated Pulmonary Diagnoses in Lung Transplant Patients in the United States

    T. G. Mupfudze1, A. R. Wilk1, R. R. Goff1, M. Valapour2, J. Miller3, M. Budev2, E. D. Lease4

  • Prevalence and Clinical Significance of Pancreatic Cystic Lesions in Immunosuppressed Patients with Solid Organ Transplantation

    Y. Yu, H. Jo, Y. Choi, J. Lee, D. Kim

  • Prevalence of Mycophenolate Mofetil (MMF) Discontinuation and Outcomes in Pediatric Kidney Transplants (PKTX): A PNRC Study

    A. Moudgil1, K. Sgambat1, E. Benoit2, A. Jain3, M. Seifert4, C. Katsoufis5, L. Harshman6, A. Mansuri7, M. Somers8

  • Prevention of the Progression in Chronic Calcineurin Inhibitors Nephrotoxicity via Steroids Anti-Inflammatory Effects

    N. Iwahara1, K. Hotta1, Y. Tanaka1, I. Takahashi1, R. Hasebe1, H. Okada1, T. Tsuji2, Y. Takada2, H. Higuchi2, H. Sasaki1, T. Tanabe1, D. Iwami3, N. Shinohara1, M. Murakami1

  • Pro- and Anti-Tolerogenic Microbiota Induce Distinct Gut Microbiome Metabolic Pathways and Loco-Regional Immune Responses

    S. J. Gavzy1, R. Lakhan2, J. Iyyathurai2, V. Saxena2, Z. L. Lee2, B. Ma2, E. Mongodin2, J. S. Bromberg2

  • Process Evaluation of the Ascent Study: A Hybrid Type 1 Effectiveness-Implementation Trial of a Multi-Level Intervention to Improve Dialysis Provider Knowledge of Kidney Allocation Policy Changes and Increase Kidney Transplant Waitlisting

    M. A. Urbanski1, Y. Lee1, M. Basu1, C. Escoffery2, R. Hamoda1, L. Plantinga3, S. O. Pastan1, R. E. Patzer1

  • Processing Personal Activity Tracker (PAT) Through Artificial Intelligence (AI) is a Promising Method to Identify Patterns of Physical Activity in Liver Transplant (LT) Candidates

    A. Duarte-Rojo1, P. M. Bloomer1, J. M. Jakicic2, E. Sejdic3

  • Production of Exosomal IL35 from Alloreactive Treg Cells: A Basis for Potent Immunotherapy and Tolerance in Human Kidney Transplantation

    W. J. Burlingham1, E. Jankowska-Gan2, J. Fechner1, C. Little1, S. Tripathi3, B. Schreiber3, A. Chandraker3, D. Foley4

  • Prognostic Factors for Mortality of COVID-19 Infection in Kidney Transplant Recipients in Thailand: A Nationwide Study

    A. Banjongjit1, N. Larpparisuth2, K. Phonphok3, P. Homkrailas4, O. Traitanon5, P. Inkong6, S. Wongpraphairot7, A. Lumpaopong6, T. Supaporn6, C. Pongskul8

  • Programmatic Fidelity is Central to the Development of Virtual Living Donor Kidney Transplantation Educational Programs

    A. Carter, H. Qu, R. Reed, A. C. Killian, V. Kumar, M. J. Hanaway, J. Locke

  • Progression from Kidney Transplant Referral to Initiating the Pre-Transplant Evaluation: What Causes the Break Down?

    T. Menser, M. J. Hobeika, E. Hsu, L. W. Moore, A. D. Waterman, A. O. Gaber, R. J. Knight

  • Progression of Peripheral Vascular Disease After Kidney/Pancreas Transplantation

    R. J. Knight, E. A. Graviss, D. T. Nguyen, Y. Ye, S. G. Yi, C. S. Bavare, A. R. Sadhu, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber

  • Prolonged Preservation by Hypothermic Machine Perfusion Facilitates Logistics in Liver Transplantation: A European Observational Cohort Study

    I. M. Brüggenwirth1, M. Mueller2, V. A. Lantinga1, S. Camagni3, R. De Carlis4, L. De Carlis5, M. Colledan6, D. Dondossola7, M. Drefs8, J. Eden2, D. Ghinolfi9, D. Koliogiannis10, G. Lurje11, T. Manzia12, D. Monbaliu13, P. Muisean14, D. Patrono15, J. Pratschke16, R. Romagnoli17, M. Rayar18, F. Roma14, A. Schlegel2, P. Dutkowski2, R. J. Porte1, V. E. de Meijer1

  • Prolonged Xeno-Kidney Graft Survival in Highly Allo-Sensitized Nonhuman Primate Using Triple-Knockout Donor Pigs with 7 Human Transgenes

    M. Manook1, D. Olaso1, I. Anwar1, J. Yoon1, M. Song1, A. B. Farris2, K. Stiede3, K. Hall3, M. Youd3, S. Knechtle1, J. Kwun1

  • Prospective Analysis of the Impact of Impella 5.5 Devices on HLA Antibody Development in Transplant Recipients

    K. Castro, J. Van Zyl, R. Doss, S. McKean, J. Russelia, A. Alam, M. Askar, S. Hall

  • Prospective Evaluation of Donor-Derived Cell-Free DNA (dd-cfDNA) in Monitoring Response to Anti-Rejection Treatment in Kidney Transplant Recipients with Indication Biopsy

    L. Benning1, A. Fink2, F. Kälble1, C. Speer1, C. Nusshag1, M. Zeier1, C. Süsal3, C. Morath1, T. Tran2

  • Prospective Study of Preimplantation Biopsy in Deceased Donor Kidney Transplantation (DDKT)

    H. Me, M. Smith, C. Jadlowiec, K. Harris, R. Butterfield, H. Khamash, B. G. AbuJawdeh, K. Reddy, R. Heilman

  • Protective Immunity Against a Murine Epstein-Barr Virus Homolog is Preserved During CD11b-CD154 Blockade

    K. L. Alexander, D. Liu, M. L. Ford

  • Protein and Transcriptomic Differences Between High and Low Neointimal Arteries in Human Cardiac Allograft Vasculopathy Rejected Grafts

    J. Nevarez-Mejia1, H. C. Pickering1, R. A. Sosa1, R. P. Lau1, G. A. Fishbein1, W. M. Baldwin III2, R. L. Fairchild2, E. F. Reed1

  • Proteinuria in Diseased Kidney Transplant Donors for Prediction of Chronic Lesions in Pre-Transplant Biopsies – A Prospective Observational Study

    F. Haupenthal1, J. Kläger2, F. Bauernfeind3, A. Heinzel1, K. Doberer1, K. Mayer1, L. Naar1, M. Eigenschink1, K. Hu1, H. Regele2, T. Szekeres4, R. Reindl-Schwaighofer1, G. Bond1

  • Proteome Profiling of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) Plasma Samples Reveals Potential Proteins Involved in Primary FSGS

    L. Gallon1, N. Ahsan2, V. Mas3, J. Leventhal1, L. Fornelli2

  • Proteomic Profiling of Bile from Human Livers Undergoing Viability Assessment via Normothermic Machine Perfusion Prior to Transplantation

    A. M. Thorne1, J. C. Wolters2, F. Kuipers1, R. J. Porte1, V. E. de Meijer1

  • Protocolized, Broad-Based Renal Genetic Testing in the Management of Patients at a Transplant Center

    V. Paramasivam1, P. Shehzad1, B. Greco1, K. Gaj2, M. Germain3

  • Pseudomonas Related Pseudoaneurysm and Rupture of Transplant Renal Artery with Devastating Consequences – A Case Series

    S. Umapathy1, S. Nielsen1, A. Curtis1, A. Reyad1, J. Guiteau1, N. Umezurike1, S. Patel1, W. Miller2, L. Ostrosky-Zeichner2, M. Madhrira3, I. Memon3, B. Sankarapandian3, S. Allam3

  • PSGL-1-mTOR-TIM3 Signaling in a Murine Model of Hindlimb Transplantation

    K. Kadono1, F. Messner2, J. He2, Y. Guo2, B. Oh2, G. Brandacher2, J. Kupiec-Weglinski1

  • PTLD Suspected by Visualization of Atypical Urinary Lymphocytes

    J. Huidobro E1, F. Anghileri2, P. Troncoso3, A. Huete4, P. Downey1

  • Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A National Survey

    E. Pope-Collins, M. Nickels, K. Dokus, J. Martens, E. Keller, R. Hernandez-Alejandro, B. Al-Judaibi

  • Pulmonary Function Tests and Liver Transplantation

    D. Reino1, P. Martinez2, K. Robichaux3, M. Gosselin4, S. Mohammed3, J. Buggs1, A. Kumar5

  • Pulsatile Kidney Perfusion Improves Survival and Graft Function in High Acuity Combined Liver Kidney Transplant (CLKT) Recipients

    T. Liu1, G. Panayotova2, F. Paterno3, A. Amin2, L. Brown4, J. Guarrera5, K. Lunsford6

  • Pump Resistance Thresholds and Graft Outcomes in Machine Perfused Kidneys-A Single Center Retrospective Study

    S. Sivan, J. Gaynor, M. Tabbara, G. Ciancio

  • Pure Laparoscopic Donor Right Hepatectomy (PLDRH) – Can It be a Standardized, Reproducible and Cost Effective Procedure?

    A. Kadimella, B. Palat, R. S

  • Pure Laparoscopic versus Open Right Hepatectomy in Living Liver Donors (Graft Weight Discrepancy)

    J. Seo1, S. Hong1, S. Lee2, S. Suh2, S. Hong1, E. Han1, Y. Choi2, N. Yi2, K. Lee3, K. Suh1

Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences